GenomeX Data Exchange FHIR IG
0.2.0 - draft
GenomeX Data Exchange FHIR IG, published by MITRE. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/CodeX-HL7-FHIR-Accelerator/GenomeX-DataExchange/ and changes regularly. See the Directory of published versions
Generated Narrative: Observation HereditaryCancerTestingOverInterNegative
status: Final
category: Laboratory
code: Discrete variation analysis overall interpretation
value: Negative
component
code: Conclusion Text
value: Organization HRD Status: NEGATIVE
component
code: Genetic Result: Negative - No Clinically Significant Mutation Identified
value: Note: "CLINICALLY SIGNIFICANT", as defined in this report, is a genetic change that is associated with the potential to alter medical intervention.
component
code: Breast Cancer Risk Assessment Tool (assessment scale)
value: Breast Cancer RiskScore®: Remaining Lifetime Risk 10.9%
component
code: Clinical History Analysis: No additional management guidelines identified based on the clinical history provded
value: Other clinical factors may influence the individualized management. This analysis may be incomplete if details about cancer diagnoses, ages, family relationships or other factors were omitted or ambiguous. If this patient also has a clinically significant mutation, the recommendations based on the clinical history analysis should be considered in light of the possibility that this mutation explains all or some of the cancer history in the family.